Increased gene dosage of myelin protein zero causes Charcot‐Marie‐Tooth disease
Meiko Hashimoto Maeda(The University of Tokyo), Shoji Tsuji(The University of Tokyo), Hideyuki Matsumoto(Mitsui Memorial Hospital), Shin Hayashi(Tokyo Medical and Dental University), Johji Inazawa(Shanghai Institute for Science of Science), Yuji Takahashi(The University of Tokyo), Jun Mitsui(The University of Tokyo), Sahoko Miyama(Tokyo Metropolitan Children's Medical Center), Tomoko Okamoto(Tokyo National Hospital), Yuichiro Shirota(The University of Tokyo), Bing‐Wen Soong(Children's Oncology Group), Yaeko Ichikawa(The University of Tokyo), Jun Shimizu(Shimane University), Hiroyuki Ishiura(The University of Tokyo), Jun Goto(Kumamoto University), Makoto Arai(Tokyo Metropolitan Institute of Medical Science)
Cited by 37
Related Papers
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
|Nature Genetics|2004|1.6k
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
|Movement Disorders|2022|788
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714
Exploration of Tumor-Suppressive MicroRNAs Silenced by DNA Hypermethylation in Oral Cancer
|Cancer Research|2008|618